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Objective: The use of cross-sectional area (CSA) measurements obtained from computed tomographic angiography (CTA)
for the calculation of carotid artery stenosis has been suggested but not yet validated in a large population. The objective
of this study was to determine whether CTA-derived CSA measurements were able to predict carotid stenosis with a level
of conﬁdence similar to CTA-derived diameter measurements, using Strandness criteria applied to carotid duplex
ultrasound (CDUS) as a surrogate for true stenosis.
Methods: A retrospective review was conducted to identify patients who underwent both CDUS and CTA between 2000 and
2009. Percent stenosis was calculated using the North American Symptomatic Carotid Endarterectomy Trial (NASCET)
formula with diameter measurements and again with CSA measurements. A nonparametric correlation coefﬁcient was
calculated to detect correlation between the two groups. Two-dimensional receiver-operating characteristic curves with cor-
responding area under the curve (AUC) statistics were generated for >50% stenosis and >80% stenosis. Three-dimensional
receiver-operating characteristic plots with corresponding volume under the surface (VUS) statistics were generated to
measure the comparative accuracy of diameter-based and CSA-based stenosis for <50%, 50%-79%, and >80% stenosis.
Results: A total of 575 vessels in 313 patients were included in the study. Spearman’s correlation coefﬁcient between
diameter and CSA-derived stenosis was r[ 0.938 (95% conﬁdence interval [CI], 0.927-0.947; P < .0001). For diameter-
derived stenosis, AUC was 0.905 (95% CI, 0.878-0.932; P < .0001) for >50% stenosis and 0.950 (95% CI, 0.928-0.972;
P < .0001) for 80%-99% stenosis. For CSA-derived percent stenosis, the AUC was 0.908 (95% CI, 0.882-0.935;
P < .0001) for >50% stenosis and 0.935 (95% CI, 0.908-0.961; P < .0001) for 80%-99%. The nonparametric estimate for
VUS in the diameter-based stenosis group was 0.761, whereas in the CSA-based group, the VUS was 0.735. The
difference between VUS was 0.026 (95% CI, e0.022 and 0.077; P [ .318).
Conclusions: These data support the use of CTA as an accurate method of calculating carotid artery stenosis based on
agreement with Strandness criteria applied to CDUS velocities. When additional imaging beyond CDUS is necessary, we
report no signiﬁcant difference between diameter and CSA measurements obtained from CTA for preoperative evaluation
of carotid disease. (J Vasc Surg 2013;58:659-65.)Current recommendations suggest carotid duplex ultra-
sound (CDUS) to be the imaging modality of choice for
screening the asymptomatic population at risk for carotid
artery stenosis.1 The Society for Vascular Surgery guidelines
further suggest that additional imaging in the form of digital
subtraction angiography (DSA), computed tomographic
angiography (CTA), or magnetic resonance angiography
be performed in patients with (1) nondiagnostic CDUS,
(2) asymptomatic stenosis of intermediate severity, or (3)the Division of Vascular Surgery, University of Rochester School of
edicine and Dentistry.
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://dx.doi.org/10.1016/j.jvs.2013.02.031need for evaluation of vessels proximal or distal to the
cervical carotid arteries.1 With multiple imaging modalities
available, disagreement has arisen among clinicians as to
which technique offers the most accurate characterization
of stenosis. The preferred imaging modality is often
institution-speciﬁc and requires consideration of several vari-
ables including availability of angiography suites, use of
nephrotoxic contrast, operator skill, and patient tolerance
of the examination.2-7
Diameter measurements obtained from DSA have been
the gold standard in the evaluation of carotid stenosis. This
technique provided the clinical data needed to validate the
use of velocity data obtained from duplex ultrasonography
as a less invasive means of diagnosing carotid disease.8-10
CTA, however, represents a less-invasive imaging option
available for preoperative evaluation of patients in whom
ultrasound results are nondiagnostic. CTA allows for multi-
plane diameter measurements, which may provide increased
accuracy compared withmeasurements obtained from tradi-
tional two-dimensional DSA. Several studies support this
conclusion, suggesting diameter measurements obtained
from CTA may be as accurate as those obtained from DSA
when used in the North American Symptomatic Carotid659
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carotid stenosis.11-15 Furthermore, CTA may also provide
useful prognostic information regarding plaquemorphology
such as ulceration and calciﬁcation.16
An additional beneﬁt of CTA is the ability to obtain
cross-sectional area (CSA) measurements of a stenotic
vessel’s ﬂow lumen. One may hypothesize that CSA gives
the best approximation of a vessel’s ﬂow lumen and, there-
fore, provides the most accurate depiction of carotid
stenosis, particularly in the setting of an irregularly shaped
lumen (Fig 1). Previous studies, however, report conﬂict-
ing results as to whether an irregularly shaped lumen may
introduce error into stenosis estimation using the NASCET
equation.17,18 The use of CSA measurements for the calcu-
lation of carotid artery stenosis has, therefore, been sug-
gested but not yet validated in a large population. The
objective of this study was to determine whether CTA-
derived CSA measurements were able to predict carotid
stenosis with a level of conﬁdence similar to CTA-derived
diameter measurements, using Strandness criteria applied
to CDUS as a surrogate for true stenosis.
METHODS
A retrospective review was performed using a combina-
tion of International Classiﬁcation of Diseases, Ninth Revi-
sion and Current Procedural Terminology codes to identify
patients with suspected carotid disease who underwent both
CDUS and CTA between 2000 and 2009 at the University
of Rochester Medical Center. Data from both inpatient and
outpatient imaging facilities were used in the study. Patients
were included if they underwent CTA within 6 months of
a CDUS study. Patients with complete occlusion of one
carotid artery as demonstrated by computed tomography
and conﬁrmed by duplex were excluded from the study to
prevent inclusion of patients with falsely elevated velocities.19
Vessels with prior carotid endarterectomy or stent placement
were excluded from the study. Patients with missing peak
systolic velocity (PSV), end diastolic velocity (EDV), or PSV
internal carotid artery/common carotid artery (ICA/CCA)
ratio data on CDUS were also excluded from the study.
Variables collected included patient demographic
information and CDUS velocities (PSV, EDV, and PSV
ICA/CCA ratio). Diameter and CSA measurements at
the point of maximum stenosis and at the distal ICA
were obtained by a single study author after undergoing
training and veriﬁcation of measurement technique by
an attending vascular surgeon. In heavily calciﬁed vessels,
an edge enhancement tool built into the imaging software
was used to aid with delineation of the calcium-contrast
interface. A sample (n ¼ 58) of vessels was remeasured
by both the author who obtained the original measure-
ments and by a second study author to calculate intra/inter-
observer reliability. All study authors were blinded to
patients’ ultrasound velocities and clinical data prior to
CTA measurement. All measurements were obtained from
axial images. Distal measurements were taken at a disease
free portion of the ICAno fewer than 2mmdistal to luminal
stenosis. CSAmeasurements of the patent ﬂow lumen weretaken from the same axial slices that were used to obtain
diameter measurements. CSA was quantiﬁed using
Centricity RIS-IC software (v. 10.6.0.999; GEHealthcare,
Little Chalfont, United Kingdom) with a built-in pixel-
based image-processing algorithm requiringmanual outline
of the lumen being examined.
CTA studies were obtained using Philips Brilliance
(Koninklijke Philips Electronics NV, Amsterdam, The
Netherlands) 64-slice scanners imaging from the ascending
aorta to the vertex in helical mode with 64-  0.625-mm
collimation, 100 kVp and 300 to 400 mA adjusted per
patient size. Peripheral intravenous access was obtained
with an 18- or 20-gauge catheter after conﬁrmation of
current lab values. A total of 75 mL of intravenous contrast
was administered at a rate of 5 mL/s. A bolus-triggering
technique was used with region of interest in the ascending
aorta at the beginning of the aortic arch. Standard axial sli-
ces of 0.8 mm thickness at increments of 0.4 mm were
obtained. Postprocessing reformats were subsequently per-
formed but not used in this study.
Diameter measurements were used in the NASCET
equation to determine diameter percent stenosis. Similarly,
CSA measurements were used in the NASCET equation
to determine CSA percent stenosis (Fig 2). Patients with
stenosis calculations resulting in negative values were
assumed to have 0% stenosis. Duplex velocities were
used to quantify percent stenosis based on Strandness
duplex velocity criteria for <50% stenosis (PSV < 125
cm/s and EDV < 140 cm/s), 50%-79% stenosis (PSV
> 125 cm/s and EDV < 140 cm/s), and 80%-99%
stenosis (PSV > 125 cm/s and EDV > 140 cm/s).
Three different methodologies were applied to assess
differences between diameter and CSA-based techniques.
First, a simple scatter plot comparing diameter percent
stenosis vs CSA percent stenosis was generated, and
Spearman’s nonparametric correlation coefﬁcient was
calculated. Second, the ultrasound data were used as
a surrogate for true stenosis for the creation of two-
dimensional receiver-operating characteristic (ROC)
curves. Strandness ultrasound criteria were used in two-
dimensional ROC curve generation to divide the data in
a binary (yes/no) fashion for >50% stenosis and again
for 80%-99% stenosis. Area under the curve (AUC) was
calculated for each ROC curve, and the difference
between AUCs was tested statistically. Lastly, three-
dimensional ROC surface plots were generated to
describe the probability of correct classiﬁcation into three
diagnostic groups (<50%, 50%-79%, and 80%-99%
stenosis) based on Strandness diagnostic thresholds.
Volume under ROC surface (VUS) was calculated to
measure the overall diagnostic accuracy of diameter-
based and CSA-based stenosis. The difference between
VUS values was calculated and statistically tested for
differences. Conventional statistical analyses were per-
formed using GraphPad Prism 6 (GraphPad Software
Inc, La Jolla, Calif). The difference in AUCs for corre-
lated ROC curves was tested using the pROC package
in R software. DiagTest3Grp package in R software was
Fig 1. Graphic representation of the variability between commonly used measurement techniques for evaluation of
carotid artery stenosis. CT, Computed tomographic.




(n ¼ 575) Signiﬁcance
Mean age 6 SD 70.7 6 12.5 70.8 6 12.7 P ¼ .91
Male, No. (%) 178 (56.9) 321 (55.8) P ¼ .77
Female, No. (%) 135 (43.1) 254 (44.2) P ¼ .77
Comorbidities, No. (%)
Diabetes 94 (30.0) 173 (30.1) P ¼ .99
Prior CVA 40 (12.8) 78 (13.6) P ¼ .84
Prior MI 33 (10.5) 60 (10.4) P ¼ .99
Documented CAD 104 (33.2) 188 (32.7) P ¼ .88
Smoking 166 (53.0) 300 (52.2) P ¼ .83
HTN 230 (73.5) 421 (73.2) P ¼ .99
Hypercholesterolemia 172 (55.0) 314 (54.6) P ¼ .94
Medications, No. (%)
Beta blocker 144 (46.0) 266 (46.3) P ¼ .94
Aspirin 203 (64.9) 366 (63.7) P ¼ .77
Clopidogrel 53 (16.9) 93 (16.2) P ¼ .78
Warfarin 24 (7.7) 45 (7.8) P ¼ .99
Diuretic 102 (32.6) 180 (31.3) P ¼ .71
Calcium channel
blocker
60 (19.2) 107 (18.6) P ¼ .86
CAD, Coronary artery disease; CVA, cerebrovascular accident; HTN,
hypertension; MI, myocardial infarction; SD, standard deviation.
The column labeled Patients includes individual patients without duplicates,
regardless of whether they contributed one or two vessels to the study. The
column labeled Vessels allows for duplicates, as patients are counted twice if
they contributed two vessels to the study.
Fig 2. Top, Traditional North American Symptomatic Carotid
Endarterectomy Trial (NASCET) method using diameter measure-
ments to approximate carotid stenosis. Bottom, Investigational
technique using cross-sectional area (CSA) measurements to
approximate carotid stenosis.
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Bootstrap resamples were performed to test for the differ-
ence in VUS.
RESULTS
A total of 575 vessels in 313 patients (136 females and
177 males) were included in the study (Table); 255 vessels
were from females and 320 were from males. Mean age at
ultrasound was 70.8 years (IQR, 63.5 e 80.7 years; SEM,
0.53 years). There were 43 vessels in the 80%-99% stenosis
group, 201 vessels in the 50%-79% stenosis group, and 331
vessels in the<50% stenosis group. A comparison of diameter
measurements with ultrasound data grouped by Strandness
criteria for>50% stenosis yielded a sensitivity of 72.1%, spec-
iﬁcity of 94.3%, positive predictive value (PPV) of 90.3%, and
negative predictive value (NPV) of 82.1%. Similarly, CSA
measurements for calculationof>50%stenosis yieldeda sensi-
tivity of 75.0%, a speciﬁcity of 93.1%, a PPV of 88.8%, and anNPV of 83.5%. Diameter measurements for calculation of
80%-99% stenosis yielded a sensitivity of 62.7%, a speciﬁcity
of 97.2%, a PPV of 64.3%, and an NPV of 97.0%. CSA
measurements for calculation of 80%-99% stenosis yielded
Fig 3. Scatter plot demonstrating correlation between stenosis
calculated from diameter measurements vs cross-sectional area
(CSA) measurements.
Fig 4. Receiver-operating characteristic (ROC) curves demon-
strating the ability of bothdiametermeasurements (Diameter stenosis)
and cross-sectional area measurements (CSA stenosis) to detect
stenosis of >50%.
Fig 5. Receiver-operating characteristic (ROC) curves demon-
strating the ability of both diameter measurements (Diameter
stenosis) and cross-sectional area measurements (CSA stenosis) to
detect stenosis of >80%.
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and an NPV of 98.2%. Spearman’s correlation coefﬁcient for
intraobserver reliability was calculated to be r ¼ 0.951
(95% conﬁdence interval [CI], 0.919-0.971; P < .0001) for
diameter measurements and r ¼ 0.957 (95% CI, 0.929-
0.975;P< .0001) for CSAmeasurements. Spearman’s corre-
lation coefﬁcient for interobserver reliability was calculated to
be r¼ 0.838 (95%CI, 0.740-0.901;P< .0001) for diameter
measurements and r ¼ 0.901 (95% CI, 0.837-0.940;
P < .0001) for CSA measurements. A sample size of n ¼ 30
vessels was calculated to yield 95% power to detect a correla-
tion of 0.6 or greater. The sample size was subsequently
increased to n ¼ 58 to ensure sufﬁcient power to detect a
lower degree of correlation.
Spearman’s correlation coefﬁcient between diameter
percent stenosis and CSA percent stenosis was r ¼ 0.938
(95% CI, 0.927-0.947; P < .0001) (Fig 3). For diameter
percent stenosis, AUC was 0.905 (95% CI, 0.878-0.932;
P < .0001) for >50% stenosis (Fig 4) and 0.950 (95% CI,
0.928-0.972; P < .0001) for 80%-99% stenosis (Fig 5).
For CSA percent stenosis, the AUC was 0.908 (95% CI,
0.882-0.935; P < .0001) for >50% stenosis (Fig 4) and
0.935 (95% CI, 0.908-0.961; P < .0001) for 80%-99%
(Fig 5). The difference between AUCs for diameter and
CSA for >50% stenosis was nonsigniﬁcant (P ¼ .675) under
alpha¼ .05. The difference between AUCs for diameter and
CSA for 80%-99% stenosis was also nonsigniﬁcant
(P ¼ .162) under alpha ¼ .05. The nonparametric estimate
for VUS in the diameter percent stenosis group was 0.761
(Fig 6, A), whereas in the CSA percent stenosis group,
the VUS was 0.735 (Fig 6, B). The difference between
VUS was 0.026 (95% CI, e0.022 and 0.077; P ¼ .318)
showing nonsigniﬁcance under alpha ¼ .05.
DISCUSSION
The use of CTA for the diagnosis and assessment of
carotid stenosis is now a commonly used clinical toolwhen imaging beyond CDUS is required. Advantages of
using CTA over DSA include its less invasive nature, the
ability to obtain multiplanar views, and better visualization
of plaque characteristics and morphology. Axial imaging
and centerline reconstructive techniques allow radiogra-
phers to take precise three-dimensional measurements
that were previously unobtainable with DSA. Both diam-
eter and CSA of a vessel’s ﬂow lumen can be easily
measured at various locations along the length of a
stenotic vessel. Drawbacks to CTA include its inability to
demonstrate important hemodynamic variables, nephro-
toxic effects of contrast, exposure to radiation, and
expense. Vessel tortuosity also poses a challenge when
evaluating stenosis on axial images, although centerline
Fig 6. Three-dimensional receiver-operating characteristic (ROC) surface plots depicting the ability of diameter
measurements (A) and cross-sectional area (CSA) measurements (B) to characterize carotid stenosis. True fraction 1
describes the probability of the test correctly placing a patient in the <50% stenosis group; true fraction 2 likewise for
the 50%-79% stenosis group; and true fraction 3 for the >80% stenosis group.
JOURNAL OF VASCULAR SURGERY
Volume 58, Number 3 Carnicelli et al 663reconstruction may be employed in these instances to
minimize ambiguities.
The use of CSA for evaluation of carotid stenosis is not
a novel concept. Over a decade ago, Cinat et al described
a high degree of correlation between true percent lumen
reduction using CSA and both NASCET and European
Carotid Surgery Trial (ECST) stenosis calculated from
conventional angiographic measurements.14 More re-
cently, Prehn et al used diameter, CSA, and volumetric
measurements to calculate both NASCET and ECST
stenosis in a small cohort of patients.20 The results demon-
strate only modest correlation between CSA and duplex
peak systolic velocities as well as a similarly modest corre-
lation between CSA and duplex-based stenosis grading
using Strandness grading criteria.20 These results raise
the question of whether such ﬁndings can be generalized
to the more diverse target population of those patients
in whom there is clinical suspicion of carotid disease.
Our study employs a large sample size to suggest that
CSA percent stenosis can classify carotid disease as accurately
as traditional diameter percent stenosis derived from CTA.
This conclusion is supported by a lack of signiﬁcant difference
between ROC AUC values for >50% and 80%-99% stenosis
categories. Spearman’s correlation coefﬁcient for diameter
percent stenosis vs CSA percent stenosis also supports this
conclusion. In addition, we suggest that ROC surface analysis
using the VUS calculation is the most accurate and appro-
priate statistical measure of accuracy in this setting. The use
of two-dimensional ROC curves limits investigators to the
study of tests with binary outcomes, such as >50% or >80%
stenosis. Two-dimensional ROC curves, therefore, provideno information about the important 50%-79% stenosis group.
This third diagnostic group is sufﬁciently accounted for by
ROC surface analysis, which is speciﬁcally designed to detect
the overall accuracy of a diagnostic test in which there are
three possible categorical outcomes. The three-dimensional
ROC surface with VUS analysis has been shown to be both
valid and reproducible in this setting.21-25
While some think of VUS as a three-dimensional
version of the standard two-dimensional AUC, there are
several key differences that make VUS a more appropriate
test in our study. First, VUS calculations from ROC surface
plots are designed to demonstrate the probability of accu-
rately placing a patient with a given degree of stenosis into
one of three categorical disease groups. Second, a VUS
value of 0.167 may be thought of as similar to an AUC
value of 0.5. In other words, both of these values describe
a noninformative test. This can be conceptualized by un-
derstanding that VUS describes the probability that vessels
from the <50% stenosis group, the 50%-79% stenosis
group, and the 80%-99% stenosis group are correctly
ordered. Since there are three factorial (3! ¼ 6) ways to
order the three groups, the probability of correctly or-
dering the three groups if the diagnostic test provides
no information is 1/6 ¼ 0.167. In both the two-
dimensional AUC and the three-dimensional VUS,
a perfect test is deﬁned by a value of 1. Our VUS data
demonstrate a similar degree of accuracy between percent
stenosis calculated from diameter vs CSA measurements.
One drawback of our study is the inability to test CSA
and diameter measurements from CTA directly against
DSA. The lack of a true gold standard in the study allows
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ities (CDUS, diameter-based CTA measurements, and
CSA-based CTA measurements) are equally inaccurate
compared with DSA. Although we acknowledge this as
a possibility, we suggest that this is not the case. We believe
that Strandness CDUS criteria may, in certain circum-
stances, be used as a surrogate for the true gold standard,
as these and similar criteria have been rigorously studied
against DSA.26-28 At our institution, it is not standard of
care for patients to undergo DSA in the preoperative eval-
uation of carotid stenosis, and therefore, the vast majority
of patients in our sample did not have DSA. Those patients
with intraoperative DSA images saved in the imaging
system unfortunately did not contain an object of reference
within the images by which measurements could be cali-
brated. The direct comparison of DSA vs CSA measure-
ments would be a meaningful study, although it would
likely need to be performed in prospective fashion and
would only include high-risk patients with unclear anatomy
or those undergoing stenting.
Another potential limitation to this study is the
assumption that carotid vessels within an individual patient
can be treated as if they are independent of each other.
There may in fact be a relationship between the severities
of disease found within a single patient’s carotid vessels,
although this theory is not necessarily apparent within
our dataset.
Last, although we are reporting a lack of signiﬁcant
difference between diameter and CSA measurements ob-
tained from CTA, our study does not, however, address
the question of whether CSA measurements are able to
predict risk of stroke more or less accurately than diameter
measurements. Additional trials are needed to evaluate
whether CSA measurements provide additional informa-
tion about clinical outcomes.
CONCLUSIONS
In conclusion, our data support the use of CTA as an
accurate method of calculating carotid artery stenosis based
on agreement with Strandness criteria applied to CDUS
velocities. When additional imaging above CDUS is neces-
sary, we report no signiﬁcant difference between diameter
and CSA measurements obtained from CTA for preopera-
tive evaluation of carotid disease.
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